echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > UK NICE recommends Rinvoq for psoriatic arthritis patients

    UK NICE recommends Rinvoq for psoriatic arthritis patients

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Psoriatic arthritis (PsA) is an inflammatory disease in which the patient's immune system produces inflammation, which can lead to skin damage, painful swelling, and stiffness in the joints
    .
    PsA is a chronic inflammatory joint disease associated with psoriasis, which is a seronegative inflammatory arthritis with several clinical features that distinguish it from rheumatoid arthritis


    (RA) .


    Immune Rheumatoid Arthritis The UK National Institute for Health and Care Excellence (NICE) has issued a Final Assessment Decision (FAD) recommending Rinvoq (upadacitinib) as a new option for the treatment of adults with active psoriatic arthritis (PsA)


    Upadacitinib is an oral, once-daily selective and reversible Janus kinase inhibitor (JAKi)


    .


    Upadacitinib is an oral, once-daily selective and reversible Janus kinase inhibitor (JAKi)


    St.
    George's University Hospitals NHS Foundation Dr.
    Trust Fund rheumatology consultant Arvind Kaul said: "NICE recommended upadacitinib provides another effective treatment option for patients with psoriatic arthritis activity in England and Wales
    Clinical studies show.
    , upadacitinib can improve musculoskeletal symptoms, psoriasis, pain and fatigue in people with psoriatic arthritis


    .


    fund

     

    Original source:

    Original source:

    https:// href="https://" target="_blank" rel="noopener">https:// https:// Leave a comment here

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.